European Approval Authority checks Approval Application for Tenofir Alafenemid (TAF) for the Treatment of chronic Hepatitis B

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2016年 / 32卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：142 / 142
页数：1
相关论文
共 50 条
  • [1] HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOLLOWING TENOFOVIR ALAFENAMIDE (TAF) APPROVAL
    Curry, M.
    Bae, H.
    Dieterich, D.
    Ankoma-Sey, V
    Reddy, R.
    Pan, C.
    Hann, H. W.
    Tong, M.
    Kim, W. R.
    Kwo, P.
    Frazier, L.
    Cox, K.
    Milligan, S.
    Afdhal, N.
    VALUE IN HEALTH, 2020, 23 : S169 - S169
  • [2] Checkpoint modulation in chronic hepatitis B: From hypothesis to approval
    Germanidis, Georgios
    Hytiroglou, Prodromos
    Vassiliadis, Themistoklis
    Speletas, Matthaios
    HEPATOLOGY, 2018, 67 (03) : 1175 - 1176
  • [3] Approval of Entecavir requested for the treatment of H&Ag-negative chronic Hepatitis B
    Sankawa, Yuri
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2006, 44 (09):
  • [4] Oral treatment for hepatitis B gets approval in United States
    Josefson, D
    BRITISH MEDICAL JOURNAL, 1998, 317 (7165): : 1034 - 1034
  • [5] Practice Recommendation for the Treatment of Chronic Hepatitis C - Approval of the Polymerase Inhibitor Sofosbuvir
    Sarrazin, Christoph
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 311 - 313
  • [6] EMA confirmed Gilead's Approval Application for the Fixed Combination Sofosbuvir/Velpatasvir for the Treatment of chronic Hepatitis C
    Munsel, Daria
    VISCERAL MEDICINE, 2016, 32 (01) : 66 - 66
  • [7] European approval for mononine® as continuous intravenous infusion therapy in treatment of hemophilia B
    不详
    THROMBOSIS AND HAEMOSTASIS, 2004, 91 (03) : VIII - VIII
  • [8] Antiviral therapy for chronic hepatitis D. European Commission grants full approval for bulevirtide (Hepcludex®)
    不详
    VISCERAL MEDICINE, 2023, 39 (05) : 152 - 152
  • [9] COST-EFFECTIVENESS OF TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF CHRONIC HEPATITIS B IN TAIWAN
    Tan, E. C. H.
    Yehoshua, A.
    Jeyakumar, S.
    Peng, P.
    Lin, A. Y.
    Smith, N.
    Kachru, N.
    VALUE IN HEALTH, 2022, 25 (12) : S145 - S145
  • [10] The European Commission has granted Marketing Authorization for VEMLIDY® (Tenofoviralafenamide, TAF) from Gilead for the Treatment of chronic Hepatitis-B-Infection
    不详
    VISCERAL MEDICINE, 2017, 33 (01) : 91 - 91
12345